Status | Study |
Completed |
Study Name: Gene Polymorphism Associated With Macroangiopathy in Type 2 Diabetes Patients Condition: Diabetic Angiopathies Date: 2016-08-25 Interventions: Other: Group A 150 healthy blo |
Enrolling by invitation |
Study Name: Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia Condition: Critical Limb Ischemia Arteriosclerosis Obliterans Periphe Date: 2016-08-05 Interventions: Procedure: ADRC injection 10 m |
Recruiting |
Study Name: Microcirculation and Bone Metabolism in Patients With Type 2 Diabetes Mellitus and Charcot Foot - A Pilot Study Condition: Diabetic Angiopathies Bone Diseases, Metabolic Date: 2015-04-27 Interventions: Other: Baseline comparison of microcirculation and bone metabolism Baseline comparison of microcirculati |
Active, not recruiting |
Study Name: Arterial Calcification in the Diabetes Condition: Diabetic Vascular Diseases Arteriosclerosis Obliterans Date: 2015-04-27 Interventions: Other: serum RANKL |
Completed |
Study Name: Measurement of Endothelial Function With Peripheral Arterial Tonometry in Patients Undergoing Hyperbaric Oxygen Therapy Condition: Diabetic Peripheral Vascular Disease Date: 2014-08-19 |
Completed |
Study Name: Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers Condition: Diabetic Foot Ulcers Date: 2014-07-31 Interventions: Other: AMNIOEXCEL Application |
Active, not recruiting |
Study Name: Arterial Stiffness and Complication Risk in Type 2 Diabetes Condition: Diabetes Mellitus, Type 2 Diabetes Complications Date: 2013-11-21 |
Terminated |
Study Name: ECM and Blood Components for Wound Healing Condition: Ulcer Venous Ulcer Foot Ulcer, Diabetic Date: 2013-07-25 Interventions: Device: ECM ECM in saline appl |
Completed |
Study Name: Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy Condition: Diabetic Retinopathy Retinal Diseases Eye Diseases Date: 2012-12-06 Interventions: Drug: Ranibizumab Intravitreal |
Completed |
Study Name: Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study Condition: Diabetic Macular Edema Date: 2011-12-02 Interventions: Drug: Macugen® pegaptanib sodium Patients assigned to |